Comments
Jubilant Cadista Pharmaceuticals Inc is recalling 63,216 bottles of Pantoprazole Sodium delayed-release tablets in the American market and Puerto Rico, as per the latest report of the US health regulator.
The tablets are used for the short-term treatment of erosive esophagitis associated with gastroesophageal reflux disease (GERD).
Jubilant Cadista Pharmaceuticals Inc is recalling 63,216 bottles of the tablets in the strength of 40 mg, manufactured by Jubilant Generics Ltd at its Roorkee plant, the Enforcement Report of the US Food and Drug Adminstration said.
The reason for the recall is “CGMP Deviation: Presence of dark brown discoloration on edges of tablets,” it added.
The ongoing voluntary recall is a class II recall, the report said.
“The product was distributed to Mississippi, Ohio, Rhode Island, Tennessee and Puerto Rico to distributors and wholesalers who may have further distributed the product to the retail level,” it added.
As per the USFDA, a class II recall is initiated in a situation “in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.”
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.